IL-1 beta and IL-6 in community-acquired pneumonia: Bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia

被引:33
作者
Lieberman, D
Livnat, S
Schlaeffer, F
Porath, A
Horowitz, S
Levy, R
机构
[1] KUPAT HOLIM KLALIT,SOROKA MED CTR,NATL CTR MYCOPLASMA,BEER SHEVA,ISRAEL
[2] KUPAT HOLIM KLALIT,SOROKA MED CTR,INFECT DIS LAB,BEER SHEVA,ISRAEL
[3] BEN GURION UNIV NEGEV,FAC HLTH SCI,IL-84101 BEER SHEVA,ISRAEL
关键词
D O I
10.1007/BF02113582
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Interleukin-l beta (IL-1 beta) and interleukin-6 (IL-6) levels in 20 patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia (CAP) were compared with these cytokine levels in 20 patients with Mycoplasma pneumoniae CAP. All 40 patients survived hospitalization and underwent a follow-up examination one month later, Serum IL-1 beta and IL-6 levels were determined by the enzyme immunoassay (EIA) method using commercial kits, In the acute phase of CAP, IL-6 levels were significantly higher in the S. pneumoniae group (p = 0.014), while IL-1 beta levels were higher in the M. pneumoniae group (p = 0.046), In the convalescence phase, the two cytokines were detected in a considerable number of patients in both groups. In this phase, only the level of IL-l beta was significantly higher in the M. pneumoniae group than in the S. pneumoniae group (p = 0.03), We conclude that the levels of IL-1 beta and IL-6 are different between patients with S, pneumoniae-CAP and M. pneumoniae-CAP during the acute phase, In the convalescence phase, cytokine levels remain high in some of the CAP patients, but a significant difference between the groups exists only for IL-1 beta. Further studies are required.
引用
收藏
页码:90 / 94
页数:5
相关论文
共 20 条
[1]   COMMUNITY-ACQUIRED PNEUMONIA [J].
BARTLETT, JG ;
MUNDY, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1618-1624
[2]   CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].
BEUTLER, B ;
KROCHIN, N ;
MILSARK, IW ;
LUEDKE, C ;
CERAMI, A .
SCIENCE, 1986, 232 (4753) :977-980
[3]   HIGH CIRCULATING LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH SEPTIC SHOCK - EVOLUTION DURING SEPSIS, PROGNOSTIC VALUE, AND INTERPLAY WITH OTHER CYTOKINES [J].
CALANDRA, T ;
GERAIN, J ;
HEUMANN, D ;
BAUMGARTNER, JD ;
GLAUSER, MP .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 (01) :23-29
[4]   PROGNOSTIC VALUES OF TUMOR-NECROSIS-FACTOR CACHECTIN, INTERLEUKIN-1, INTERFERON-ALPHA, AND INTERFERON-GAMMA IN THE SERUM OF PATIENTS WITH SEPTIC SHOCK [J].
CALANDRA, T ;
BAUMGARTNER, JD ;
GRAU, GE ;
WU, MM ;
LAMBERT, PH ;
SCHELLEKENS, J ;
VERHOEF, J ;
GLAUSER, MP .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (05) :982-987
[5]   PLASMA CYTOKINE AND ENDOTOXIN LEVELS CORRELATE WITH SURVIVAL IN PATIENTS WITH THE SEPSIS SYNDROME [J].
CASEY, LC ;
BALK, RA ;
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) :771-778
[6]   TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 SERUM LEVELS DURING SEVERE SEPSIS IN HUMANS [J].
DAMAS, P ;
REUTER, A ;
GYSEN, P ;
DEMONTY, J ;
LAMY, M ;
FRANCHIMONT, P .
CRITICAL CARE MEDICINE, 1989, 17 (10) :975-978
[7]   THE ROLE OF MEDIATORS IN HUMAN ARDS [J].
DEMLING, RH .
JOURNAL OF CRITICAL CARE, 1988, 3 (01) :56-72
[8]  
HACK CE, 1989, BLOOD, V74, P1704
[9]  
HELFGOTT DC, 1989, J IMMUNOL, V142, P948
[10]   APACHE - ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION - A PHYSIOLOGICALLY BASED CLASSIFICATION-SYSTEM [J].
KNAUS, WA ;
ZIMMERMAN, JE ;
WAGNER, DP ;
DRAPER, EA ;
LAWRENCE, DE .
CRITICAL CARE MEDICINE, 1981, 9 (08) :591-597